Patents Assigned to Salix Pharmaceuticals
  • Use of 2-hydroxy-5-phenylazobenzoic acid derivatives as colon cancer chemopreventative and chemotherapeutic agents
    Patent number: 5498608
    Abstract: The present invention provides a method of colon cancer chemoprevention or chemotherapy comprising administering to an individual suffering from colon cancer or at risk to develop colon cancer a pharmaceutical composition comprising an effective amount of a 2-hydroxy-5-phenylazobenzoic acid derivative or an ester of an active metabolite thereof, or a pharmacologically acceptable salt of the 2-hydroxy-5-phenylazobenzoic acid derivative or an ester or an active metabolite thereof.
    Type: Grant
    Filed: January 7, 1994
    Date of Patent: March 12, 1996
    Assignee: Salix Pharmaceuticals
    Inventors: Lorin K. Johnson, Marvin H. Sleisenger